🏥 Healthcare 🔬 Switch to Pharma
All Services Performance Marketing SEO & AEO / LLM YouTube Marketing LLM Optimization Brand & Growth Consulting AI Solutions Industries We Serve
Enterprise Hub · All Solutions + Services Growth Transformation AI Transformation Revenue Operations Fractional CGO Growth Operating System Executive Growth Advisory
Clinic Launch Programme (Hub) NABH Consulting India Healthcare Brand Launch Clinic SOP Creation Logo Design (Healthcare) Brand Book Creation Clinic Launch Marketing D2C Brand Launch Clinic Interior Design
Workforce Hub For Employers — post a requirement For Professionals — register Public Openings Training Academy AI Training Flagship
Hawk · CRM Intelligence (NEW) YODA · YouTube Intelligence Beacon · Attribution Agency OS · Dashboards Phoenix · Clinic Revenue HealthPro 360 · PMS/HMS AI Patient Lifecycle Bots AI Lead Management System Smart Appointment System Healthcare CRM Patient Feedback System AI, Analytics & Automation Digital Transformation Free Tools Free Digital Health Audit →
All Events Workshop 1 · Jun 13 · AI in Clinical Practice Workshop 2 · Jun 27–28 · AI in Growth & Governance Hospital Ops Workshop · Jul 12 Pre-Summit Seminar · Aug 16 Grand Summit 2.0 · Oct 10–11 Bihar AI Summit · Recap AI Innovation Awards · Aug 22 Grand Summit 2.0 · Oct 2026 Aarambh 2026 Recap
Case Studies Insights & Blog Research Reports Free Tools AI in Healthcare Digest
Our Story Team Abhash Kumar Deep Das Rohit Gupta Speakers & Panelists Careers
Book a Growth Diagnostic
We Do It Right. The right diagnosis. The right strategy. The right systems. Giving healthcare leaders the confidence to make better decisions, build stronger operations, and achieve sustainable growth. — Team Ichelon
Trusted by 150+ healthcare & life-sciences brands
Johnson & Johnson
Mankind Pharma
Adonis Phyto
Narang Biotec
Medanta
Redcliffe Labs
Sitaram Bhartia
Metro Hospitals
Tulasi Hospital
Bloom IVF
Milann
Prime IVF
MedLinks
Handa
Bhardwaj
Eye Q
Johnson & Johnson
Mankind Pharma
Adonis Phyto
Narang Biotec
Medanta
Redcliffe Labs
Sitaram Bhartia
Metro Hospitals
Tulasi Hospital
Bloom IVF
Milann
Prime IVF
MedLinks
Handa
Bhardwaj
Eye Q
Johnson & Johnson
Mankind Pharma
Adonis Phyto
Narang Biotec
Medanta
Redcliffe Labs
Sitaram Bhartia
Metro Hospitals
Tulasi Hospital
Bloom IVF
Milann
Prime IVF
MedLinks
Handa
Bhardwaj
Eye Q
Meta Ads · Audience Strategy · 2026

Broad vs Narrow Meta Ad Audiences for Healthcare — The Per-Specialty Verdict

Published 27 June 2026 · ICG Editorial · 7 min read
The broad vs narrow audience debate has been going for years. Most healthcare brands pick one philosophy and stick with it. Both philosophies are wrong as fixed positions — the right answer changes weekly based on saturation, competition, and seasonality. Meta Catalyst IQ delivers the verdict per account, weekly. Here's the per-specialty baseline.

Why "broad always" and "narrow always" are both wrong

The fixed-philosophy camps each have an argument:

Both are right sometimes and wrong other times. The right framing isn't "what's my philosophy" — it's "what's the verdict for my account this week."

Per-specialty audience baselines

Across the ICG portfolio, the typical optimal audience size by specialty:

Why the answer shifts week-to-week

Three factors shift the broad vs narrow optimal:

1. Audience saturation

Run a 5M narrow audience for 8-12 weeks; you'll exhaust the optimal pool. CPL rises. Same week, expanding to 15M broader audience can reduce CPL because the algorithm finds adjacent intent signals in the wider pool.

2. Competitive intensity

When a competitor enters your specialty + city with aggressive Meta spend, your narrow audience CPM rises faster than the broader audience CPM (because competitors target the same narrow pool). Shifting broader during a competitor escalation can preserve CPL.

3. Seasonality

Aesthetic specialties around festival + wedding season: broader audience works because everyone is in-market. Off-season: narrower works because only intent-driven patients are searching.

The weekly verdict methodology

Meta Catalyst IQ's Audience Size verdict each Monday checks 5 inputs:

  1. CPL by audience size bucket (≤2M, 2-10M, 10-20M, 20M+) over last 7 days
  2. Hold Rate by audience size bucket
  3. Result Rate by audience size bucket
  4. CPM trend by bucket (rising → saturation signal)
  5. Frequency by bucket (high frequency → saturation imminent)

The output: which audience size delivered best CPL × engagement quality this week, and the reallocation recommendation for next week (typically 10-25% budget shift).

The compounding logicBrands that reallocate weekly based on data outperform brands with fixed strategies by 12-18% CPL annually. The shift isn't dramatic any single week (10-15% budget movement); it compounds.

3 common mistakes in audience strategy

  1. Building 50+ ad sets for granularity. Meta's algorithm needs 50-100 conversions per ad set to optimise. With 50 ad sets, none get to threshold. Better: 5-12 ad sets with broader audiences, let the algorithm optimise within.
  2. Refusing to test broader. The "we know our patient" instinct keeps brands locked into narrow audiences past saturation. Test broader monthly even if you don't expect it to win.
  3. Not segmenting NRI vs domestic. NRI audiences have completely different economics + targeting needs. Should never be in the same ad set as domestic.

Get your account's audience verdict.

ICG runs a 48-hour audit on your Meta account that surfaces current audience size performance, saturation signals, and the recommended reallocation. Read-only OAuth access.

Book a free audit →

Related reading

Chat with a Co-Founder
Chat with a Co-Founder